Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

15.1K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.1K
Cross-bridge Cycle01:26

Cross-bridge Cycle

118.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.0K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.0K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
Mitochondria01:37

Mitochondria

14.3K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.3K
Mitochondrial Membranes01:45

Mitochondrial Membranes

11.9K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological Activation of NRF2 by Omaveloxolone Upregulates NRF2-Target Proteins in SMA Type I Human Fibroblasts.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Clinical relevance of zebrafish for gene variants testing. Proof-of-principle with SMN1/SMA.

EMBO molecular medicine·2025
Same author

Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study.

Journal of neuromuscular diseases·2025
Same author

Multitasking Proteins: Exploring Noncanonical Functions of Proteins during Mitosis.

Biochemistry·2025
Same author

An ultra-conserved poison exon in the Tra2b gene encoding a splicing activator is essential for male fertility and meiotic cell division.

The EMBO journal·2025
Same author

Functional Insights in PLS3-Mediated Osteogenic Regulation.

Cells·2024

Related Experiment Video

Updated: Aug 28, 2025

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.5K

Mitochondrial Dysfunction in Spinal Muscular Atrophy.

Eleonora Zilio1, Valentina Piano1,2,3,4, Brunhilde Wirth1,2,3,4

  • 1Institute of Human Genetics, University Hospital of Cologne, University of Cologne, 50931 Cologne, Germany.

International Journal of Molecular Sciences
|September 23, 2022
PubMed
Summary

Spinal muscular atrophy (SMA) is linked to SMN1 gene mutations. This review explores how SMN loss impacts mitochondria, suggesting mitochondrial repair as a potential therapy for this neuromuscular disorder.

Keywords:
SMN1SMN2cellular homeostasismitochondriamitochondria biogenesis and dynamicsmotor neuron diseasesneurodegenerationneurodegenerative diseasesoxidative stressspinal muscular atrophy

More Related Videos

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.7K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.8K

Related Experiment Videos

Last Updated: Aug 28, 2025

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.5K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.7K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.8K

Area of Science:

  • Neurology
  • Genetics
  • Cell Biology

Background:

  • Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder caused by mutations in the SMN1 gene.
  • Disease severity correlates with reduced levels of functional Survival Motor Neuron (SMN) protein.
  • SMN protein is crucial for numerous cellular functions, including RNA binding.

Purpose of the Study:

  • To review the impact of SMN loss on mitochondrial function in neuronal and muscular tissues affected by SMA.
  • To explore the contribution of mitochondrial dysfunction to SMA progression.
  • To identify potential therapeutic strategies targeting mitochondrial restoration in SMA.

Main Methods:

  • Review of existing literature on SMA and mitochondrial function.
  • Analysis of transcripts encoding mitochondrial proteins in SMA models.
  • Correlation of SMN levels with mitochondrial health.

Main Results:

  • SMN deficiency significantly affects mitochondrial function in neurons and muscles.
  • Mitochondrial defects are implicated in the pathogenesis and progression of SMA.
  • A list of affected mitochondrial protein transcripts in SMA models was compiled.

Conclusions:

  • Mitochondrial dysfunction is a key factor in SMA.
  • Restoring mitochondrial functionality presents a promising therapeutic avenue for SMA.
  • Age-related mitochondrial decline may trigger adult-onset SMA, necessitating tailored therapeutic approaches.